Title : Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis.

Pub. Date : 2021 Jul 20

PMID : 34316328






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The phytochemical and bioactive agent sulforaphane (SFN) has nutrigenomic potential in activating the expression of several cellular protective genes via the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). sulforaphane NFE2 like bZIP transcription factor 2 Homo sapiens
2 The phytochemical and bioactive agent sulforaphane (SFN) has nutrigenomic potential in activating the expression of several cellular protective genes via the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). sulforaphane NFE2 like bZIP transcription factor 2 Homo sapiens
3 The phytochemical and bioactive agent sulforaphane (SFN) has nutrigenomic potential in activating the expression of several cellular protective genes via the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). sulforaphane NFE2 like bZIP transcription factor 2 Homo sapiens
4 The phytochemical and bioactive agent sulforaphane (SFN) has nutrigenomic potential in activating the expression of several cellular protective genes via the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). sulforaphane NFE2 like bZIP transcription factor 2 Homo sapiens